Physician profile
Lisa Leone
NPI 1902845506
$5,504.98
in general payments reported to CMS, 2019-2025
31 companies · $1,061 in 2025
The $1,061 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $699 · 2020: $268 · 2021: $664 · 2022: $921 · 2023: $1,067 · 2024: $823 · 2025: $1,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,951.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,396.96 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $519.36 | 2021-2025 | |
| Exeltis, USA INC. | $380.36 | 2022-2025 | Slynd, Twirla |
| Hologic Sales and Service, LLC | $353.06 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Amgen INC. | $302.07 | 2019-2025 | Evenity, Prolia |
| Aspira Women'S Health INC | $284.02 | 2021-2024 | Ova1 |
| Astellas Pharma US INC | $276.76 | 2020-2025 | Veozah |
| Sumitomo Pharma America, INC. | $226.71 | 2023-2024 | Myfembree, Gemtesa |
| Coopersurgical, INC. | $215.48 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $201.68 | 2021-2024 | |
| Millicent US INC | $170.14 | 2019-2025 | Intrarosa, Femlyv, Femring |
| Sage Therapeutics, LLC | $155.07 | 2022-2025 | Zurzuvae |
| Shield Therapeutics INC | $143.64 | 2023-2025 | Accrufer |
| Organon LLC | $125.56 | 2022-2024 | Nexplanon |
| Evofem Biosciences, INC. | $102.66 | 2021-2025 | Phexxi, Solosec, Phexx |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $79.05 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $60.02 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.10 | 2019-2022 | |
| Avion Pharmaceuticals | $51.58 | 2020-2023 | Balcoltra |
| Baxter Healthcare | $47.62 | 2024 | Perclot |
| Myovant Sciences INC. | $47.32 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $43.53 | 2023-2025 | Gardasil 9, Gardasil |
| Therapeuticsmd, INC. | $41.87 | 2021-2022 | |
| Agile Therapeutics, INC. | $38.59 | 2021-2022 | |
| Urovant Sciences INC | $38.25 | 2022 | |
| Duchesnay USA Incorporated | $34.84 | 2019 | |
| Henry Schein, INC. | $28.09 | 2024 | |
| Amag Pharmaceuticals, INC. | $27.03 | 2019-2020 | |
| Medtronic, INC. | $24.89 | 2023 | Truclear |
| Mylan Pharmaceuticals INC. | $16.23 | 2021 | |
| Meditrina | $15.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Leone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.